Navigation Links
Celladon Corporation Receives Patent from United States Patent and Trademark Office
Date:7/19/2012

SAN DIEGO, July 19, 2012 /PRNewswire/ -- Celladon Corporation, a biopharmaceutical company focused on the discovery and development of innovative treatments for cardiovascular diseases, announced today that the United States Patent and Trademark Office (USPTO) issued U.S. Patent No. 8,221,738 with claims that cover the administration of MYDICAR, Celladon's first in class drug under clinical evaluation for advanced heart failure. The patent, titled "Methods of enhanced uptake of viral vectors in the myocardium" carries a patent term to at least March, 2030. A similar application has been filed with the EU Patent Office (EPO).

"This is yet another important addition to our evolving patent portfolio for MYDICAR. The allowance further strengthens MYDICAR's market exclusivity protection in the United States" said Krisztina Zsebo Ph.D., President and CEO of Celladon Corp. "This is the second important patent granted to MYDICAR this year and we will continue the pursuit of additional patent grants relevant to our products on a global basis."

About MYDICAR

MYDICAR is a genetically targeted enzyme replacement therapy intended to restore levels of SERCA2a, a regulator of calcium cycling in the heart and cardiac contractility. SERCA2a levels decline in all forms of late-stage heart failure resulting in deficient heart function. With MYDICAR, the SERCA2a gene is delivered using recombinant adeno-associated virus (AAV) as the vector. AAV is a naturally occurring virus not associated with any disease in humans. MYDICAR is delivered in a single dose directly to the heart during a routine outpatient cardiac catheterization procedure, similar to an angiogram. MYDICAR is synergistic and additive across current heart failure treatments such as ACE inhibitors, beta-blockers, sprinolactone/diuretics, and biventricular pacing devices. No treatment substitution decision is required by the treating physician.

About Heart Failure

Chronic heart fai
'/>"/>

SOURCE Celladon Corporation
Copyright©2012 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine technology :

1. Celladon Corporation Receives Notice of Allowance from European Patent Office
2. Gentris Corporation Launches New Pharmacogenomics Services
3. BioElectronics Corporation Announces Initiative for UK and German Markets
4. Luminex Corporation Second Quarter Earnings Release Scheduled for July 30, 2012
5. Luminex Corporation Announces Agreement to Acquire GenturaDx
6. Statement from Mary Vogt, President of Home Access Health Corporation, manufacturer of the Home Access HIV-1 test system, the only over-the-counter HIV test previously approved by the FDA for at-home use.
7. Gentris Corporation Partners with the Shanghai Institutes of Preventative Medicine
8. BioElectronics Corporation Announces Indian Distributors Ecommerce Website
9. FMC Corporation Acquires Phytone, Ltd., a Leading European Natural Colors Business
10. Volcano Corporation Presentation at Wells Fargo Conference to be Webcast
11. Centene Corporation Selected for Ohio Medicaid Contract
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/23/2013)... May 23, 2013  Intercept Pharmaceuticals, Inc. (Nasdaq: ... focused on the development and commercialization of novel bile ... primary biliary cirrhosis, today announced that Mark ... will present at the Deutsche Bank Securities 38th Annual ... on Wednesday, May 29, 2013 at 4:10 p.m. ET. ...
(Date:5/23/2013)... May 23, 2013  Omeros Corporation (NASDAQ: ... New Drug Application (IND) to evaluate OMS824 in ... Food and Drug Administration (FDA). OMS824 selectively inhibits ... of the brain linked to a wide range ... and schizophrenia. OMS824 has shown promising results in ...
(Date:5/23/2013)... -- MedVantx, Inc., the company that has pioneered a unique ... Company has completed a major expansion of its home ... the upgrade of its systems to offer a level ... home delivery pharmacy in Sioux Falls, SD ... health systems and payors novel distribution services, as well ...
Breaking Medicine Technology:Investigational New Drug Application Cleared by FDA for OMS824 in Huntington's Disease 2Investigational New Drug Application Cleared by FDA for OMS824 in Huntington's Disease 3Investigational New Drug Application Cleared by FDA for OMS824 in Huntington's Disease 4MedVantx Achieves Significant Milestone of Managing $1.5B in Prescription Medications and Completes Facilities Expansion While Upgrading To Offer Current Good Manufacturer Practices (cGMP)-level Quality Systems in their Home Delivery Pharmacy 2MedVantx Achieves Significant Milestone of Managing $1.5B in Prescription Medications and Completes Facilities Expansion While Upgrading To Offer Current Good Manufacturer Practices (cGMP)-level Quality Systems in their Home Delivery Pharmacy 3
(Date:5/23/2013)... (HealthDay News) -- The sensation of itching is hardwired ... to a small molecule released in the spinal cord, ... Researchers say this molecule, known as natriuretic polypeptide b ... nervous system. Ultimately, this signal is experienced as an ... are similar, the researchers concluded that a similar process ...
(Date:5/23/2013)... HealthDay Reporter , , THURSDAY, May 23 (HealthDay News) -- ... badly as methamphetamine or crack cocaine, a new study ... mouth, or ,coke mouth, it is startling to see ... the same," said Dr. Mohamed Bassiouny, a professor of ... in Philadelphia. Methamphetamine, crack cocaine and soda -- ...
(Date:5/23/2013)... used virus isolated from a person who died from ... could infect and be transmitted between ferrets. Ferrets are ... and efficient transmission of influenza virus between ferrets can ... might occur in people. The research was supported, in ... Diseases, part of the National Institutes of Health. , ...
(Date:5/23/2013)... IL (PRWEB) May 23, 2013 ... comprehensive solutions and educational resources for the autism, ... that it is opening its first global autism ... the Philippines in August. This new world-class program ... best of Western evidence-based practices to treat and ...
(Date:5/23/2013)... OAK BROOK, Ill. (May 23, 2013) Aortic arch ... a strong independent predictor of disease of the vessels ... new study published in the June issue the journal ... the aortic arch provides functional information about vessel compliance ... disease down the road," said Kevin S. King, M.D., ...
Breaking Medicine News(10 mins):Health News:Got an Itch? Mouse Study May Help Explain Why 2Health News:Diet Soda Habit as Bad for Teeth as Meth Addiction, Study Claims 2Health News:Diet Soda Habit as Bad for Teeth as Meth Addiction, Study Claims 3Health News:Ferrets, pigs susceptible to H7N9 avian influenza virus 2Health News:Special Learning, Inc. to Expand its Services for Individuals with Special Needs with Opening of New Special Education School in the Philippines 2Health News:Special Learning, Inc. to Expand its Services for Individuals with Special Needs with Opening of New Special Education School in the Philippines 3Health News:MRI-based measurement helps predict vascular disease in the brain 2
... ... Pharma has introduced Nyloxin OTC, an over-the-counter pain reliever, that will be marketed ... Rx. , ... Plantation, FL (Vocus) November 19, 2009 -- Nutra Pharma Corp. (OTCBB: NPHC), ...
... , DALLAS and JACKSONVILLE, Fla., Nov. 19 ... and CEO Christopher T. Fey today announced the national launch ... individual and group preventive health care efforts. , A key ... a health management program based on the science of clinical ...
... Nov. 19 The Northeast Assisted Fertility Group (NAFG), already ... York, is pleased to announce the opening of a new office ... in the Miami area. , Ever since it was founded, ... And now, with its newly expanded pool of donors, carriers, and ...
... There are minimal data assessing the relationship between diabetes ... have suggested an elevated risk of pancreatic cancer only ... research article published on November 14, 2009 in the ... The research team, lead by Dr. Jamal at the ...
... Elsevier, the leading publisher of scientific, technical and medical information ... available Special Issue of Child Abuse and Neglect The ... U.N. Convention on the Rights of the Child (CRC). , ... the adoption of the UN Convention on the Rights of ...
... as annual day to ,butt out, for good , THURSDAY, Nov. ... you,ll have, says the American Cancer Society as it encourages smokers ... Smokeout. , Research shows that smokers who quit at age 35 ... who quit at 55 gain about five years. Even long-time smokers ...
Cached Medicine News:Health News:Nutra Pharma Introduces Chronic Pain Reliever, Nyloxin OTC, for International Distribution 2Health News:Nutra Pharma Introduces Chronic Pain Reliever, Nyloxin OTC, for International Distribution 3Health News:U.S. Preventive Medicine Introduces The Prevention Score(TM) 2Health News:U.S. Preventive Medicine Introduces The Prevention Score(TM) 3Health News:NAFG Expands Surrogacy and Egg Donation Program into Miami 2Health News:Elsevier celebrates the 20th anniversary of the UN Convention for the Rights of the Child 2Health News:Great American Smokeout '09: Time to Quit 2
Shandon Paraffin Block Cartons...
The Tissue Cassette Storage Cabinet is made of strong, laminated fiberboard....
... The first ... and efficiently manage ... process. Proven technology ... and collates cassettes ...
Improving on the technology that the world has come to expect from the original SHUR/Mark® Cassette and Slide Labelers, SHUR/Mark® PLUS offers many added enhancements....
Medicine Products: